158 related articles for article (PubMed ID: 16732184)
1. Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness.
Emmer PM; van der Vlag J; Adema GJ; Hilbrands LB
Transplantation; 2006 May; 81(10):1451-9. PubMed ID: 16732184
[TBL] [Abstract][Full Text] [Related]
2. Programmed death-1 signaling is essential for the skin allograft protection by alternatively activated dendritic cell infusion in mice.
Dai H; Zhu H; Lei P; Yagita H; Liu J; Wen X; Zhou W; Gong F; Shen G; Fang M
Transplantation; 2009 Oct; 88(7):864-73. PubMed ID: 19935456
[TBL] [Abstract][Full Text] [Related]
3. Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells.
Roelen DL; Schuurhuis DH; van den Boogaardt DE; Koekkoek K; van Miert PP; van Schip JJ; Laban S; Rea D; Melief CJ; Offringa R; Ossendorp F; Claas FH
Transplantation; 2003 Dec; 76(11):1608-15. PubMed ID: 14702533
[TBL] [Abstract][Full Text] [Related]
4. Induction of donor-specific T-cell hyporesponsiveness using dexamethasone-treated dendritic cells in two fully mismatched rat kidney transplantation models.
Stax AM; Gelderman KA; Schlagwein N; Essers MC; Kamerling SW; Woltman AM; van Kooten C
Transplantation; 2008 Nov; 86(9):1275-82. PubMed ID: 19005410
[TBL] [Abstract][Full Text] [Related]
5. Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides.
Giannoukakis N; Bonham CA; Qian S; Chen Z; Peng L; Harnaha J; Li W; Thomson AW; Fung JJ; Robbins PD; Lu L
Mol Ther; 2000 May; 1(5 Pt 1):430-7. PubMed ID: 10933964
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.
Emmanouilidis N; Guo Z; Dong Y; Newton-West M; Adams AB; Lee ED; Wang J; Pearson TC; Larsen CP; Newell KA
Transplantation; 2006 Feb; 81(3):455-62. PubMed ID: 16477234
[TBL] [Abstract][Full Text] [Related]
7. Immature rat myeloid dendritic cells generated in low-dose granulocyte macrophage-colony stimulating factor prolong donor-specific rat cardiac allograft survival.
DePaz HA; Oluwole OO; Adeyeri AO; Witkowski P; Jin MX; Hardy MA; Oluwole SF
Transplantation; 2003 Feb; 75(4):521-8. PubMed ID: 12605121
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta(1) gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo.
Sun W; Wang Q; Zhang L; Pan J; Zhang M; Lu G; Yao H; Wang J; Cao X
J Mol Med (Berl); 2002 Aug; 80(8):514-23. PubMed ID: 12185452
[TBL] [Abstract][Full Text] [Related]
9. Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness.
Tiao MM; Lu L; Tao R; Harnaha J; Fung JJ; Huang LT; Qian S
Transplant Proc; 2004 Jun; 36(5):1592-4. PubMed ID: 15251391
[TBL] [Abstract][Full Text] [Related]
10. Synergistic tolerance induced by LF15-0195 and anti-CD45RB monoclonal antibody through suppressive dendritic cells.
Min WP; Zhou D; Ichim TE; Xia X; Zhang X; Yang J; Huang X; Garcia B; Dutartre P; Jevnikar AM; Strejan GH; Zhong R
Transplantation; 2003 Apr; 75(8):1160-5. PubMed ID: 12717196
[TBL] [Abstract][Full Text] [Related]
11. [Effects of transforming growth factor beta1 on dendritic cells function].
Lin MF; Mou HB; Cen H
Zhonghua Xue Ye Xue Za Zhi; 2004 Aug; 25(8):449-52. PubMed ID: 15555257
[TBL] [Abstract][Full Text] [Related]
12. [Pretreatment of donor dendritic cells with NBD-peptide prolongs mouse cardiac allograft survival].
Su G; Zhao WZ; Chen JJ; Xu J; Qiao CH; Liu C; Sun ZQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1562-7. PubMed ID: 18819868
[TBL] [Abstract][Full Text] [Related]
13. Synergy in induction of increased renal allograft survival after portal vein infusion of dendritic cells transduced to express TGFbeta and IL-10, along with administration of CHO cells expressing the regulatory molecule OX-2.
Gorczynski RM; Bransom J; Cattral M; Huang X; Lei J; Xiaorong L; Min WP; Wan Y; Gauldie J
Clin Immunol; 2000 Jun; 95(3):182-9. PubMed ID: 10866124
[TBL] [Abstract][Full Text] [Related]
14. "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig.
Lan YY; Wang Z; Raimondi G; Wu W; Colvin BL; de Creus A; Thomson AW
J Immunol; 2006 Nov; 177(9):5868-77. PubMed ID: 17056511
[TBL] [Abstract][Full Text] [Related]
15. Steady state dendritic cells with forced IDO expression induce skin allograft tolerance by upregulation of regulatory T cells.
Yu G; Fang M; Gong M; Liu L; Zhong J; Feng W; Xiong P; Wang CY; Gong F
Transpl Immunol; 2008 Jan; 18(3):208-19. PubMed ID: 18047928
[TBL] [Abstract][Full Text] [Related]
16. Prolonged heart allograft survival resulted from donor-specific T-cell sequestering and removal by selective splenectomy in mice.
Zhu XH; Chen S; Chen ZK
Transplant Proc; 2004 Oct; 36(8):2448-9. PubMed ID: 15561276
[TBL] [Abstract][Full Text] [Related]
17. IL-17 production elicited by allo-major histocompatibility complex class II recognition depends on CD25posCD4pos T cells.
Benghiat FS; Craciun L; De Wilde V; Dernies T; Kubjak C; Lhomme F; Goldman M; Le Moine A
Transplantation; 2008 Apr; 85(7):943-9. PubMed ID: 18408572
[TBL] [Abstract][Full Text] [Related]
18. Adoptive transfer of FTY720-treated immature BMDCs significantly prolonged cardiac allograft survival.
Heng Y; Ma Y; Yin H; Duan L; Xiong P; Xu Y; Feng W; Fang M; Tan Z; Chen Y; Zheng F; Gong F
Transpl Int; 2010 Dec; 23(12):1259-70. PubMed ID: 20536794
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.
Ikeguchi R; Sacks JM; Unadkat JV; Solari M; Horibe EK; Thomson AW; Lee AW; Feili-Hariri M
Transplantation; 2008 Jan; 85(2):237-46. PubMed ID: 18212629
[TBL] [Abstract][Full Text] [Related]
20. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.
Zhang X; Li M; Lian D; Zheng X; Zhang ZX; Ichim TE; Xia X; Huang X; Vladau C; Suzuki M; Garcia B; Jevnikar AM; Min WP
Clin Immunol; 2008 Jun; 127(3):313-21. PubMed ID: 18358783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
